Cost-Effectiveness Of Ofatumumab Plus Chlorambucil In First-Line Chronic Lymphocytic Leukemia In The United Kingdom
Abstract
Authors
IV Pearson E Hawe S Zuluaga S Wolowacz A Haiderali
IV Pearson E Hawe S Zuluaga S Wolowacz A Haiderali
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now